Immunotherapy for children with autism and maternal immune conditions
Treatments studied
Part of Mental health clinical trials.
This trial tests whether low doses of a protein called interleukin-2 (IL-2) can help reduce the symptoms of autism in children aged 6 to 8. It is designed for children whose mothers had a specific immune system condition or a severe infection during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 and 8 years old.
- Your child has a diagnosis of autism spectrum disorder (moderate or severe).
- During pregnancy, you had an autoimmune disease or a severe infection (fever above 38.5°C for at least 48 hours).
- Your child has not had any major changes in their autism treatment in the last few weeks.
- Your child is medically able to receive IL-2 (no active infections, recent vaccines, or certain health conditions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This study is testing whether a probiotic supplement called Limosilactobacillus Reuteri might help reduce social difficulties in children with autism. It may offer a new way to support your child's social development.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.